Welcome to LookChem.com Sign In|Join Free
  • or
Z--D-Homoala-OH, also known as 2,4-Diamino-8-[4-(3-phosphonopropoxy)-3-hydroxy-1-but-3-enyl]-3(2H)-quinazolinone, is a synthetic quinazoline derivative that functions as a potent and selective inhibitor of dihydroorotate dehydrogenase (DHODH). This enzyme plays a crucial role in the de novo pyrimidine biosynthesis pathway, making it a significant target for developing antiproliferative and immunosuppressive drugs. Z--D-Homoala-OH has demonstrated its potential as an anticancer and immunosuppressive agent in preclinical studies, positioning it as a valuable compound for the creation of novel therapeutic agents to treat a range of diseases, including cancer and autoimmune disorders.

67843-72-5

Post Buying Request

67843-72-5 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

67843-72-5 Usage

Uses

Used in Pharmaceutical Industry:
Z--D-Homoala-OH is used as an anticancer agent for its ability to inhibit the DHODH enzyme, which is essential for the proliferation of cancer cells. By targeting this enzyme, Z--D-Homoala-OH can effectively suppress tumor growth and potentially treat various types of cancer.
Used in Immunosuppressive Applications:
In the field of immunology, Z--D-Homoala-OH is utilized as an immunosuppressive agent. Its inhibition of DHODH can help regulate the immune response, making it a potential treatment for autoimmune disorders where the immune system mistakenly attacks the body's own tissues.
Used in Drug Development:
Z--D-Homoala-OH is employed in the development of novel therapeutic agents due to its inhibitory effects on DHODH. Researchers and pharmaceutical companies are interested in its potential to create new drugs that can treat a variety of diseases by targeting this key enzyme in the pyrimidine biosynthesis pathway.

Check Digit Verification of cas no

The CAS Registry Mumber 67843-72-5 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 6,7,8,4 and 3 respectively; the second part has 2 digits, 7 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 67843-72:
(7*6)+(6*7)+(5*8)+(4*4)+(3*3)+(2*7)+(1*2)=165
165 % 10 = 5
So 67843-72-5 is a valid CAS Registry Number.

67843-72-5 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • Aldrich

  • (39748)  Z-β-D-Homoala-OH  ≥98.0% (HPLC)

  • 67843-72-5

  • 39748-250MG-F

  • 1,440.27CNY

  • Detail
  • Aldrich

  • (39748)  Z-β-D-Homoala-OH  ≥98.0% (HPLC)

  • 67843-72-5

  • 39748-1G-F

  • 4,444.83CNY

  • Detail

67843-72-5SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name (3R)-3-(phenylmethoxycarbonylamino)butanoic acid

1.2 Other means of identification

Product number -
Other names Z-|A-D-Homoala-OH

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:67843-72-5 SDS

67843-72-5Relevant academic research and scientific papers

Stereoselective synthesis and in vivo evaluation of the analgesic activity of polysubstituted bispidines

Plas, Aurelie,Troin, Yves,Chalard, Pierre,Marchand, Fabien,Eschalier, Alain

supporting information, p. 6070 - 6079,10 (2020/09/02)

Hetero-Michael addition on a chiral β'-amino α,β- unsaturated ketone gave, after some structural modifications, β,β'-diamino ketals. Mannich-type reactions of these diamines with an aldehyde led, with high diastereoselectivity, to trisubstituted piperidines. Another highly stereoselective Mannich cyclization, with an N-acyliminium ion generated in situ from the corresponding imide, allowed the preparation of original polycyclic bispidine derivatives. The antinociceptive effect of the three compounds prepared was evaluated in vivo by using the writhing test. If the biological results for the analgesic properties were disappointing, compared with the bispidine HZ2, which has a high affinity for opioid receptors, the modularity of the approach offered the possibility of introducing many substituents for new applications, which was promising because the bispidine core has been described to have many different activities. Total stereoselective synthesis of bispidine derivatives is achieved by using as two successive Mannich reactions key steps. This process constitutes a powerful approach toward the preparation of a polycyclic bispidine backbone with high enantioselectivity.

Diastereoselective synthesis of trisubstituted piperidines: A versatile synthon for elaboration of uncommon poly(aza)heterocyclic structures

Plas, Aurélie,Abrunhosa-Thomas, Isabelle,Chalard, Pierre,Troin, Yves

scheme or table, p. 6873 - 6876 (2012/02/05)

Hetero Michael addition on chiral β′-amino-α,β- unsaturated ketone furnished, after some structural modifications, β,β′-diaminoketals. Mannich type reaction of these diamines with an aldehyde led, with a high diastereoselectivity, to trisubstituted piperidines. Starting from a functionalized aldehyde and after subsequent deprotection of the amino group, an intramolecular Michael addition provided octahydro-2H-pyrrolo-[3,4-b]-pyridine, an uncommon framework found in compounds exhibiting biological activity.

Design and synthesis of C5 methylated L-arginine analogues as active site probes for nitric oxide synthase

Martin, Nathaniel I.,Woodward, Joshua J.,Winter, Michael B.,Beeson, William T.,Marletta, Michael A.

, p. 12563 - 12570 (2008/09/18)

The role of nitric oxide (NO) as a biological signaling molecule is well established. NO is produced by the nitric oxide synthases (NOSs, EC 1.14.13.39), a class of heme proteins capable of converting L-arginine to NO and L-citrulline. Despite the large body of knowledge associated with the NOSs, mechanistic details relating to the unique oxidative chemistry performed by these enzymes remain to be fully elucidated. Furthermore, a number of disease states are associated with either the over- or underproduction of NO, making the NOS pathway an attractive target for the development of therapeutics. For these reasons, molecular tools capable of providing mechanistic insights into the production of NO and/or the inhibition of the NOSs remain of interest. We report here the stereospecific synthesis and testing of a number of new L-arginine analogues bearing a minimal substitution, methylation at position 5 of the amino acid side chain (such analogues have not been previously reported). The synthetic approach employed a modified photolysis procedure whereby irradiation of the appropriate diacylperoxide precursors at 254 nm gave access to the required unnatural amino acids in good yields. A heme domain construct of the inducible NOS isoform (iNOSheme) was used to assess the binding of each compound to the enzyme active site. The compounds were also investigated as either inhibitors of, or alternate substrates for, the inducible NOS isoform. The results obtained provide new insight into the steric and stereochemical tolerance of the enzyme active site. These findings also further support the role of a conserved active site water molecule previously proposed to be necessary for NOS catalysis.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 67843-72-5